rs72657374

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001277115.2(DNAH11):​c.9102+8G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0162 in 1,548,870 control chromosomes in the GnomAD database, including 278 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.015 ( 18 hom., cov: 31)
Exomes 𝑓: 0.016 ( 260 hom. )

Consequence

DNAH11
NM_001277115.2 splice_region, intron

Scores

2
Splicing: ADA: 0.0001321
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: -0.150

Publications

2 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 7-21765597-G-A is Benign according to our data. Variant chr7-21765597-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 178729.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0146 (2119/144746) while in subpopulation NFE AF = 0.0186 (1232/66088). AF 95% confidence interval is 0.0178. There are 18 homozygotes in GnomAd4. There are 951 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.9102+8G>A splice_region_variant, intron_variant Intron 55 of 81 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.9102+8G>A splice_region_variant, intron_variant Intron 55 of 81 5 NM_001277115.2 ENSP00000475939.1 Q96DT5

Frequencies

GnomAD3 genomes
AF:
0.0147
AC:
2119
AN:
144622
Hom.:
18
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0125
Gnomad AMI
AF:
0.0113
Gnomad AMR
AF:
0.0162
Gnomad ASJ
AF:
0.00789
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00432
Gnomad FIN
AF:
0.00801
Gnomad MID
AF:
0.0197
Gnomad NFE
AF:
0.0186
Gnomad OTH
AF:
0.0174
GnomAD2 exomes
AF:
0.0121
AC:
2495
AN:
205850
AF XY:
0.0123
show subpopulations
Gnomad AFR exome
AF:
0.0107
Gnomad AMR exome
AF:
0.0116
Gnomad ASJ exome
AF:
0.00970
Gnomad EAS exome
AF:
0.000126
Gnomad FIN exome
AF:
0.00932
Gnomad NFE exome
AF:
0.0168
Gnomad OTH exome
AF:
0.0177
GnomAD4 exome
AF:
0.0164
AC:
23045
AN:
1404124
Hom.:
260
Cov.:
32
AF XY:
0.0160
AC XY:
11141
AN XY:
695524
show subpopulations
African (AFR)
AF:
0.0100
AC:
327
AN:
32538
American (AMR)
AF:
0.0119
AC:
480
AN:
40426
Ashkenazi Jewish (ASJ)
AF:
0.0105
AC:
250
AN:
23724
East Asian (EAS)
AF:
0.0000799
AC:
3
AN:
37536
South Asian (SAS)
AF:
0.00593
AC:
482
AN:
81246
European-Finnish (FIN)
AF:
0.00837
AC:
387
AN:
46250
Middle Eastern (MID)
AF:
0.0252
AC:
127
AN:
5034
European-Non Finnish (NFE)
AF:
0.0185
AC:
19965
AN:
1079670
Other (OTH)
AF:
0.0177
AC:
1024
AN:
57700
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
937
1874
2812
3749
4686
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
742
1484
2226
2968
3710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0146
AC:
2119
AN:
144746
Hom.:
18
Cov.:
31
AF XY:
0.0135
AC XY:
951
AN XY:
70242
show subpopulations
African (AFR)
AF:
0.0125
AC:
491
AN:
39380
American (AMR)
AF:
0.0162
AC:
223
AN:
13784
Ashkenazi Jewish (ASJ)
AF:
0.00789
AC:
27
AN:
3420
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4924
South Asian (SAS)
AF:
0.00432
AC:
19
AN:
4396
European-Finnish (FIN)
AF:
0.00801
AC:
77
AN:
9610
Middle Eastern (MID)
AF:
0.0211
AC:
6
AN:
284
European-Non Finnish (NFE)
AF:
0.0186
AC:
1232
AN:
66088
Other (OTH)
AF:
0.0172
AC:
34
AN:
1974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.529
Heterozygous variant carriers
0
95
190
285
380
475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0109
Hom.:
6
Bravo
AF:
0.0149
Asia WGS
AF:
0.00202
AC:
8
AN:
3476

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Uncertain:1Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

9102+8G>A in intron 55 of DNAH11: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence. It has been identified in 1.8% (155/8422) of European American chromosome s from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.w ashington.edu/EVS; dbSNP rs72657374). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 7 Benign:1
Oct 03, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Sep 06, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
2.0
DANN
Benign
0.80
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00013
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72657374; hg19: chr7-21805215; COSMIC: COSV60964567; API